Claims

Search Type State Status Topic Model Order Counting Over

As of snapshot 27745 under ledger-default@0.3.0.

Claim	Type	Assessment	Score	Review checks	References
AGENT used Bayesian optimization to identify solid-state formulations of mRNA vaccines in two clinically relevant LNP compositions representative of Moderna SM-102 and Pfizer-BioNTech ALC-0315; after more than two months at 37 °C they retained 100% bioactivity, and in rodents and non-human primates produced antigen-specific responses non-inferior to freshly prepared soluble vaccines delivered intramuscularly.	QUANTITATIVE	Supported	0.9975	1 of 4	79